Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-09

Clinical Trial Update: FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

View source ↗

Summary

The Seaver Autism Center at Mount Sinai is conducting a study to characterize FOXP1-related neurodevelopmental disorders using genetic, medical, and neuropsycho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features | Status: RECRUITING